Handbook of Systemic Drug Treatment in Dermatology

Herausgeber: Archer, Clive B.; Wakelin, Sarah H.; Maibach, Howard I.

• Broschiertes Buch

Produktbeschreibung

This book helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis Ltd
• 3 ed
• Seitenzahl: 304
• Erscheinungstermin: 13. Februar 2023
• Englisch
• Abmessung: 254mm x 178mm x 16mm
• Gewicht: 640g
• ISBN-13: 9780367860813
• ISBN-10: 0367860813
• Artikelnr.: 65614366

Autorenporträt

Edited by Sarah H. Wakelin, BSc, MB, BS, FRCP, Consultant Dermatologist and Honorary Seniro Lecturer, Imperial College Healthcare NHS Trust, London, UK Howard I. Maibach, MD, Professor of Dermatology, Department of Dermatology, University of California, San Francisco, USA Clive B. Archer, BSc, MBBS, MSc Med Ed, MD, PhD (Lond), FRCP, Consultant Dermatologist, St John's Institute of Dermatology, Guy's and St. Thomas' Hospitals NHS Foundation Trust, Honorary Professor of Dermatology and Immunopharmacology (UCLan) and Honorary Senior Lecturer (KCL), London, UK

Inhaltsangabe

1. Acitretin. 2. Acne Antibiotics. 3. Alitretinoin 4. Antiandrogens. 5.
Antibiotics Commonly Used for Skin Infections. 6. Antifungals. 7.
Antimalarials. 8. Antivirals. 9. Apremilast. 10. Azathioprine. 11. Azole
Antihelminths. 12. Bexarotene. 13. Ciclosporin. 14. Colchicine. 15.
Corticosteroids. 16. Cyclophosphamide. 17. Dapsone. 18. Dimethyl Fumarate.
19. Interleukin 4/13 inhibitors. 20. Interleukin (IL)-12/23 and IL-23
Inhibitors. 21. Interleukin-17. antagonists. 22. Isotretinoin. 23.
Ivermectin. 24. Intravenous Immunoglobulin. 25. Janus Kinase (JAK)
Inhibitors. 26. Malignant Melanoma Drug Treatments. 27. Methotrexate. 28.
Mycophenolate Mofetil. 29. Omalizumab. 30. Potassium Iodide. 31.
Propranolol. 32. Psoralens. 33. Rituximab. 34. Sulfapyridine &
Sulfamethoxy- pyridazine. 35. Thalidomide. 36. Tumour Necrosis Factor
Antagonists. 37. Vismodegib. 38. Systemic Treatment in Children. 39. Kidney
Disease. 40. Systemic Therapy & Liver Disease. 41. Systematic Therapy in
Older People.